Discovery and Characterization of a G Protein–Biased Agonist That Inhibits β-Arrestin Recruitment to the D2 Dopamine Receptor
…, L Duan, S Titus, M Bryant-Genevier, E Barnaeva… - Molecular …, 2014 - ASPET
A high-throughput screening campaign was conducted to interrogate a 380,000+ small-molecule
library for novel D2 dopamine receptor modulators using a calcium mobilization assay. …
library for novel D2 dopamine receptor modulators using a calcium mobilization assay. …
[PDF][PDF] Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells
…, Y Gedik, Y Jethmalani, C Bonney, E Barnaeva… - Stem Cell Reports, 2021 - cell.com
Efficient translation of human induced pluripotent stem cells (hiPSCs) requires scalable cell
manufacturing strategies for optimal self-renewal and functional differentiation. Traditional …
manufacturing strategies for optimal self-renewal and functional differentiation. Traditional …
[PDF][PDF] A defined roadmap of radial glia and astrocyte differentiation from human pluripotent stem cells
Human gliogenesis remains poorly understood, and derivation of astrocytes from human
pluripotent stem cells (hPSCs) is inefficient and cumbersome. Here, we report controlled glial …
pluripotent stem cells (hPSCs) is inefficient and cumbersome. Here, we report controlled glial …
[HTML][HTML] Efficacy and mechanism of action of low dose emetine against human cytomegalovirus
…, S Roy, R Venkatadri, YP Su, W Ye, E Barnaeva… - PLoS …, 2016 - journals.plos.org
Infection with human cytomegalovirus (HCMV) is a threat for pregnant women and
immunocompromised hosts. Although limited drugs are available, development of new agents …
immunocompromised hosts. Although limited drugs are available, development of new agents …
[HTML][HTML] DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain …
Brain injury and inflammation induces a local release of extracellular vesicles (EVs) from
astrocytes carrying proteins, RNAs, and microRNAs into the circulation. When these vesicles …
astrocytes carrying proteins, RNAs, and microRNAs into the circulation. When these vesicles …
Identification of a small-molecule inhibitor that disrupts the SIX1/EYA2 complex, EMT, and metastasis
…, L Mathews Griner, R King, E Barnaeva… - Cancer research, 2020 - AACR
… Elena Barnaeva; Elena Barnaeva … Trinidad-Pineiro, Lesley Mathews Griner, Rebecca
King, Elena Barnaeva, Xin Hu, Noel T. Southall, Marc Ferrer, Daniel L. Gustafson, Daniel P. …
King, Elena Barnaeva, Xin Hu, Noel T. Southall, Marc Ferrer, Daniel L. Gustafson, Daniel P. …
[HTML][HTML] Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration
Eya proteins are essential co-activators of the Six family of transcription factors and contain
a unique tyrosine phosphatase domain belonging to the haloacid dehalogenase family of …
a unique tyrosine phosphatase domain belonging to the haloacid dehalogenase family of …
[PDF][PDF] Identification of chemotype agonists for human resolvin D1 receptor DRV1 with pro-resolving functions
Resolution of acute inflammation is governed, in part, by specialized pro-resolving
mediators, including lipoxins, resolvins, protectins, and maresins. Among them, resolvin D1 (RvD1) …
mediators, including lipoxins, resolvins, protectins, and maresins. Among them, resolvin D1 (RvD1) …
[HTML][HTML] Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis
…, X Hu, X Xu, S Patnaik, KJ Wilson, E Barnaeva… - The FASEB …, 2019 - ncbi.nlm.nih.gov
Fibrosis is an underlying cause of cirrhosis and hepatic failure resulting in end stage liver
disease with limited pharmacological options. The beneficial effects of relaxin peptide …
disease with limited pharmacological options. The beneficial effects of relaxin peptide …
Discovery, Optimization, and Characterization of Novel D2 Dopamine Receptor Selective Antagonists
J Xiao, RB Free, E Barnaeva, JL Conroy… - Journal of medicinal …, 2014 - ACS Publications
The D2 dopamine receptor (D2 DAR) is one of the most validated drug targets for
neuropsychiatric and endocrine disorders. However, clinically approved drugs targeting D2 DAR …
neuropsychiatric and endocrine disorders. However, clinically approved drugs targeting D2 DAR …